| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/14/2014 | CN102333543B 细胞粘附抑制剂及其用途 Cell adhesion inhibitors and their use |
| 05/14/2014 | CN102325767B 7-苯氧基色满羧酸衍生物 7- phenoxy-color full-carboxylic acid derivatives |
| 05/14/2014 | CN102292335B (2s,3r)-n-2-((3-吡啶基)甲基)-1-氮杂双环[2.2.2]辛-3-基)-3,5-二氟苯甲酰胺的制备和治疗应用 (2s, 3r) -n-2 - ((3- pyridinyl) methyl) -1-azabicyclo [2.2.2] oct-3-yl) -3,5-difluorophenyl-carboxamide and therapeutic use |
| 05/14/2014 | CN102276662B 唾液酸(α-(2→6))-D-吡喃糖衍生物及其合成方法和应用 Sialic acid (α- (2 → 6)) - D- pyranose derivatives and their synthesis and application |
| 05/14/2014 | CN102266340B 一种抗结核的凝胶制剂 One kind of anti-TB gel formulation |
| 05/14/2014 | CN102264373B 用于原位肿瘤破坏疗法的免疫刺激性皂苷类 For in situ tumor destruction immunostimulatory therapy saponins |
| 05/14/2014 | CN102245599B 作为病毒复制抑制剂的新的4-氨基-4-氧代丁酰基肽 As a virus replication inhibitor new 4-amino-4-oxo-butyryl peptide |
| 05/14/2014 | CN102240281B 5<sup>′</sup>-甲氧基-3<sup>′</sup>，4<sup>′</sup>-次甲二氧基桂皮酸异丁基酰胺在制备抗抑郁药物中的应用 5 <sup> '</ sup> - methoxy -3 <sup>' </ sup>, 4 <sup> '</ sup> - times methylenedioxy cinnamic acid isobutylamides in the preparation of antidepressant drugs Application |
| 05/14/2014 | CN102228458B 一种美罗培南和舒巴坦钠的药物组合物 One kind of meropenem and sulbactam sodium pharmaceutical composition |
| 05/14/2014 | CN102209719B 新型前列腺素I<sub>2</sub>衍生物 The new prostaglandin I <sub> 2 </ sub> Derivatives |
| 05/14/2014 | CN102197029B 作为cdk抑制剂的亚砜亚胺取代的苯胺基嘧啶衍生物、其制备以及作为药物的用途 As cdk inhibitors sulfoxide imine substituted anilino pyrimidine derivatives, their preparation and use as a medicament |
| 05/14/2014 | CN102186488B 齿裂黄鹌菜提取物用于制备肝功能改善用药物组合物及用于制备肝功能改善用健康功能食品组合物的用途 Cracked teeth Youngia extract used in the preparation of liver function improved pharmaceutical composition for the preparation of liver function and improve health functional food composition with the use of |
| 05/14/2014 | CN102178643B 一种丁苯酞或其衍生物的微乳透皮凝胶剂及其制备方法 A microemulsion transdermal gel Butylphthalide or derivatives thereof and preparation method |
| 05/14/2014 | CN102149717B 二氧杂-双环[3.2.1]辛烷-2，3，4-三醇衍生物 Dioxa - bicyclo [3.2.1] octane-2,3,4-triol derivatives |
| 05/14/2014 | CN102149410B 医疗用复合有机化合物粉体及其制造方法以及悬浮液 The composite organic compound powder for medical use and its manufacturing method, and a suspension of |
| 05/14/2014 | CN102112452B 一种对δ亚型过氧化物酶增殖物激活受体具有激动作用的化合物、其制备方法和应用 A compound of the δ subtype of peroxisome proliferator-activated receptor agonism, and its preparation method and application |
| 05/14/2014 | CN102066370B 苯基-咪唑并吡啶类和哒嗪类 Phenyl - Imidazopyridines and pyridazine |
| 05/14/2014 | CN102066340B 作为syk或jak蛋白激酶抑制剂的2,6-二氨基-嘧啶-5-基甲酰胺类化合物 Jak as syk kinase inhibitors, or 2,6-diamino - pyrimidin-5-yl carboxamides |
| 05/14/2014 | CN102058647B 一种人参次苷h提取物及制备方法 One kind eriocitrin h ginseng extract and preparation methods |
| 05/14/2014 | CN102046609B 具有细胞保护效果的嘧啶衍生物及其应用 Pyrimidine derivatives having the cytoprotective effect and its application |
| 05/14/2014 | CN102040644B 丹参酮衍生物及其制备和用途 Tanshinone derivatives and their preparation and use |
| 05/14/2014 | CN101953794B 一种水飞蓟宾注射剂及制备方法 A flying water injection and preparation method silibinin |
| 05/14/2014 | CN101939336B Axl抗体 Axl antibody |
| 05/14/2014 | CN101903355B 咪唑取代的芳基酰胺 Imidazole-substituted aryl amide |
| 05/14/2014 | CN101890034B 一种胡黄连苷Ⅱ磷脂组合物及其制备方法 One kind picroside Ⅱ phospholipid composition and preparation method |
| 05/14/2014 | CN101874018B 作为新的在生理学上可用于硝酰基供体的n-羟基磺酰胺衍生物 As a new n- hydroxy sulfonamide derivatives may be used physiologically nitroxyl donor |
| 05/14/2014 | CN101838296B 一种聚炔苷的制备方法和用途 One poly acetylene glycosides preparation and use |
| 05/14/2014 | CN101801931B 作为二氢乳清酸脱氢酶抑制剂的氮杂联苯胺基苯甲酸衍生物 As a DHODH inhibitor aza biphenyl amino acid derivatives |
| 05/14/2014 | CN101795714B p53的表达促进方法和该方法中使用的p53表达促进剂 p53 and p53 expression promoting method used in the method of expression promoting agent |
| 05/14/2014 | CN101687758B 取代的联苯基羧酸类及其衍生物 Substituted biphenyl carboxylic acids and their derivatives |
| 05/14/2014 | CN101659657B 氰基取代的喹啉衍生物及其制备方法和用途 Cyano-substituted quinoline derivatives and their preparation and use |
| 05/14/2014 | CN101544678B 麦角甾-7,22-二烯-3β-醇的用途及其配方 Ergot-7,22-diene -3β- alcohol use and recipes |
| 05/14/2014 | CN101484424B 治疗化合物 Therapeutic compounds |
| 05/14/2014 | CN101328196B 获得医用纯单唾液酸神经节苷脂gm1的方法 Obtain medical pure monosialoganglioside gm1 methods |
| 05/14/2014 | CN101014607B 多硫酸酯化糖苷类及其盐 Esterified glycosides multi acids and salts |
| 05/13/2014 | US8722939 Cyclohexane-1,3-diones for use in the treatment of amyotrophic lateral sclerosis |
| 05/13/2014 | US8722930 Protease inhibitors |
| 05/13/2014 | US8722910 Diyne compositions |
| 05/13/2014 | US8722903 Indazole derivatives for the treatment of HSP9O-induced diseases |
| 05/13/2014 | US8722901 Carboxy oxazole or thiazole compounds as DGAT-1 inhibitors useful for the treatment of obesity |
| 05/13/2014 | US8722899 Desferrithiocin polyether analogues |
| 05/13/2014 | US8722895 Prolyl hydroxylase inhibitors and method of use |
| 05/13/2014 | US8722894 1,3-disubstituted-4-phenyl-1H-pyridin-2-ones |
| 05/13/2014 | US8722890 Thieno[3,2-C]pyridine kinase inhibitors with improved CYP safety profile |
| 05/13/2014 | US8722884 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 05/13/2014 | US8722883 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 05/13/2014 | US8722882 Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes |
| 05/13/2014 | US8722877 7-deazapurine modulators of histone methyltransferase, and methods of use thereof |
| 05/13/2014 | US8722866 Isoform-selective inhibitors and activators of PDE3 cyclic nucleotide phosphodiesterases |
| 05/13/2014 | US8722863 Solid state forms of fidaxomycin and processes for preparation thereof |
| 05/13/2014 | US8722746 Hydroxyphenyl derivatives and biological applications thereof |
| 05/13/2014 | US8722745 Sulfur-containing compound, method of preparation and pharmaceutical uses thereof |
| 05/13/2014 | US8722744 Galenical form for the administration of paracetamol by transmucous means |
| 05/13/2014 | US8722743 Lysine specific demethylase-1 inhibitors and their use |
| 05/13/2014 | US8722742 Chemical compounds having antiviral activity against Dengue virus and other Flaviviruses |
| 05/13/2014 | US8722741 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 05/13/2014 | US8722740 Synergetic composition comprising flavouring substances and organic acids and use thereof |
| 05/13/2014 | US8722739 Amino acid salts of prostaglandins |
| 05/13/2014 | US8722738 Acetycysteine compositions and methods of use thereof |
| 05/13/2014 | US8722737 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof |
| 05/13/2014 | US8722736 Multi-dose concentrate esmolol with benzyl alcohol |
| 05/13/2014 | US8722735 Pharmaceutical compositions having desirable bioavailability |
| 05/13/2014 | US8722733 Levodopa prodrug mesylate hydrate |
| 05/13/2014 | US8722732 Oligomer-calcimimetic conjugates and related compounds |
| 05/13/2014 | US8722731 Furanyl compounds and the use thereof |
| 05/13/2014 | US8722730 5-membered heterocyclic compound |
| 05/13/2014 | US8722728 Composition and method for treating dry eye syndrome |
| 05/13/2014 | US8722727 Antifungal agents |
| 05/13/2014 | US8722726 Substituted arylcyclopentenes as therapeutic agents |
| 05/13/2014 | US8722724 Compositions and methods for treating neoplastic diseases |
| 05/13/2014 | US8722723 Aromatic amide derivative |
| 05/13/2014 | US8722722 Raltegravir salts and crystalline forms thereof |
| 05/13/2014 | US8722721 SEC-hydroxycyclohexyl derivatives |
| 05/13/2014 | US8722720 Imidazole derivatives as IDO inhibitors |
| 05/13/2014 | US8722719 Amine compound and use for same |
| 05/13/2014 | US8722718 Inhibitors of C-FMS kinase |
| 05/13/2014 | US8722715 Antimicrobial oxazolidinone, hydantoin and imidazolidinone compositions |
| 05/13/2014 | US8722713 Synergistic antimicrobial composition of 1,2-benzisothiazolin-3-one and tris(hydroxymethyl)nitromethane |
| 05/13/2014 | US8722712 Substituted aryl 1 ,2,4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators |
| 05/13/2014 | US8722711 Acylbenzene derivative |
| 05/13/2014 | US8722710 Deuterium-enriched pioglitazone |
| 05/13/2014 | US8722709 Mineralocorticoid receptor antagonists |
| 05/13/2014 | US8722708 Substituted isoindolines as aspartyl protease inhibitors |
| 05/13/2014 | US8722707 Compositions and methods for inhibition of smooth muscle cell proliferation and neointimal hyperplasia |
| 05/13/2014 | US8722706 Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts |
| 05/13/2014 | US8722705 Methods for treating diffuse large B-cell lymphoma with 3-(4-amino-1-OXO-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with second active agents |
| 05/13/2014 | US8722704 Modulators of ATP-binding cassette-transporters |
| 05/13/2014 | US8722703 Fused amino pyridines for the treatment of brain tumors |
| 05/13/2014 | US8722702 Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 05/13/2014 | US8722701 1,2,3,4,5 6,7,8-octohydro-9-phenylacetamidoacridine, the preparation method and medical use thereof |
| 05/13/2014 | US8722700 CCI-779 formulations for parenteral administration |
| 05/13/2014 | US8722699 Iso-ergoline derivatives |
| 05/13/2014 | US8722698 Berbamine derivatives |
| 05/13/2014 | US8722697 Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof |
| 05/13/2014 | US8722696 Process for preparing particles containing an antiviral |
| 05/13/2014 | US8722695 Imidazolidinedione derivatives |
| 05/13/2014 | US8722694 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 05/13/2014 | US8722693 Salts of the Janus kinase inhibitor (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile |
| 05/13/2014 | US8722692 Compounds and compositions as Syk kinase inhibitors |
| 05/13/2014 | US8722691 Azolopyrimidines as inhibitors of cannabinoid 1 activity |